Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
Hiromichi ShirasuTomoya YokotaTakeshi KawakamiSatoshi HamauchiYusuke OnozawaHirofumi OgawaTsuyoshi OnoeKeita MoriTetsuro OnitsukaPublished in: International journal of clinical oncology (2020)
ICT-PCE may be a tolerable and potential option for unresectable LA-HNSCC patients ineligible for TPF.